215sek
4,4 %
Date:2025-05-13Time:18:00:00Latest report:Q1-2025List:First NorthTicker:CMOTEC B
Market Cap:50 msekEnterprise Value:49 msekNet Sales:7,69 msekEarnings:-13,8 msekEmployees:0ISIN:SE0009242654

Ratios

10-year key figure history for ChemoTech turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for ChemoTech with index and moving average MA50 and MA200.

Stockprice:2,15
MA50:1,41
MA200:1,65
Price/MA200:30,5 %
RSI (14):69,4
Price/MA50:52,7 %

Description

Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.

Medical Equipment